We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Medical

Bivictrix Therapeutics Limited

Status: Funded

Aug 11th 2016 - Aug 11th 2016

BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.

read more read less
Log in to view amount pledged

    Log in to view target

    £4,347,778
    pre-money valuation

    10
    investors

    £45,151
    pledge per investor

    10005270
    company number

    Active
    company status

    Previous Funding rounds
    26 Mar 24 Investing Zone £451,506 / 105%

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


Log in to view amount pledged

    Log in to view target

    £4,347,778
    pre-money valuation

    10
    investors

    £45,151
    pledge per investor

    10005270
    company number

    Active
    company status

    Previous Funding rounds
    26 Mar 24 Investing Zone £451,506 / 105%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph